glutaryl lysine  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc glutaryl lysine
    Characterization of <t>the</t> <t>SIRT5</t> crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " width="250" height="auto" />
    Glutaryl Lysine, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glutaryl lysine/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    glutaryl lysine - by Bioz Stars, 2023-03
    94/100 stars

    Images

    1) Product Images from "Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice"

    Article Title: Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice

    Journal: The Journal of Biological Chemistry

    doi: 10.1016/j.jbc.2022.101723

    Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " title="... and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA.

    Techniques Used: CRISPR, Western Blot

    Glutarylation-state of GCDH is regulated by Sirt5. A , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin or glutaryl-proteins by anti-glutaryl-lysine antibody (Glut-K) from HEK293T cells grown in complete media. Blots representative of at least three independent experiments. B , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or acylation media (DMEM without glucose, glutamine, pyruvate, 10% FBS). Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 2). C , immunoblot of immunopurified GCDH-FLAG by Flag-M2 resin from HEK293T cells grown in complete media with or without coexpressed SIRT5-HA. Blots representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG, lane 2). D , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or glutarylation media (EBSS containing 5 mM glucose, +50 mM Hepes, +0.8 mM lysine) with or without coexpressed SIRT5-HA. Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 1). E , immunoblot for pan-glutaryl lysine immunopurified proteins by endogenous GCDH and glutaryl-lysine from 3-month-old wild-type (SIRT5WT) and Sirt5 −/− (SIRT5KO) mice liver tissue that were refed or starved for 1 h following a 24 h starvation. Red arrow indicates the GCDH band within the glutaryl blot. Blots representative of at least three mice per group (n = 3 per group). F , relative quantification of the immunoblots in ( E ). Data representative of a single experiment from six SIRT5WT and six SIRT5KO mouse livers starved for 24 h from which half were refed (3 SIRT5WT and 3 SIRT5KO) normal diet for 1 h, while the remaining half (three SIRT5WT and three SIRT5KO) continued starvation for additional 1 h (mean ± SD, n = 3 per group). WT and Gcdh −/− (GCDHKO) mice (n = 1) were used as positive and negative controls, respectively, for identifying the correct GCDH band. One-way ANOVA followed by Tukey’s post hoc test was performed for multiple comparisons across groups where ∗ p -value = 0.0173, ∗∗ p -value = 0.0018, ∗∗∗ p -value = 0.0005, ∗∗∗∗ p -value < 0.0001. DMEM, Dulbecco’s modified Eagle’s medium; EBSS, Earle's Balanced Salt Solution; endo-SIRT5, endogenous SIRT5; FBS, fetal bovine serum; GCDH, glutaryl-CoA dehydrogenase.
    Figure Legend Snippet: Glutarylation-state of GCDH is regulated by Sirt5. A , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin or glutaryl-proteins by anti-glutaryl-lysine antibody (Glut-K) from HEK293T cells grown in complete media. Blots representative of at least three independent experiments. B , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or acylation media (DMEM without glucose, glutamine, pyruvate, 10% FBS). Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 2). C , immunoblot of immunopurified GCDH-FLAG by Flag-M2 resin from HEK293T cells grown in complete media with or without coexpressed SIRT5-HA. Blots representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG, lane 2). D , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or glutarylation media (EBSS containing 5 mM glucose, +50 mM Hepes, +0.8 mM lysine) with or without coexpressed SIRT5-HA. Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 1). E , immunoblot for pan-glutaryl lysine immunopurified proteins by endogenous GCDH and glutaryl-lysine from 3-month-old wild-type (SIRT5WT) and Sirt5 −/− (SIRT5KO) mice liver tissue that were refed or starved for 1 h following a 24 h starvation. Red arrow indicates the GCDH band within the glutaryl blot. Blots representative of at least three mice per group (n = 3 per group). F , relative quantification of the immunoblots in ( E ). Data representative of a single experiment from six SIRT5WT and six SIRT5KO mouse livers starved for 24 h from which half were refed (3 SIRT5WT and 3 SIRT5KO) normal diet for 1 h, while the remaining half (three SIRT5WT and three SIRT5KO) continued starvation for additional 1 h (mean ± SD, n = 3 per group). WT and Gcdh −/− (GCDHKO) mice (n = 1) were used as positive and negative controls, respectively, for identifying the correct GCDH band. One-way ANOVA followed by Tukey’s post hoc test was performed for multiple comparisons across groups where ∗ p -value = 0.0173, ∗∗ p -value = 0.0018, ∗∗∗ p -value = 0.0005, ∗∗∗∗ p -value < 0.0001. DMEM, Dulbecco’s modified Eagle’s medium; EBSS, Earle's Balanced Salt Solution; endo-SIRT5, endogenous SIRT5; FBS, fetal bovine serum; GCDH, glutaryl-CoA dehydrogenase.

    Techniques Used: Western Blot, Modification

    Glutarylation impairs GCDH activity and SIRT5 partially restores it. A , immunoblot of chemically modified GCDH (hGCDH-6xHIS) using glutaryl-CoA with or without incubation with recombinant SIRT5 (mSIRT5-6xHIS). Quantitative values of glutaryl-lysine intensity normalized to total protein are expressed as ratios relative to control (glutaryl-modified recombinant GCDH, lane 2). B , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and deglutarylated ( light purple ) GCDH determined by using PMS/DCPIP as artificial electron acceptors and glutaryl-CoA as electron donor (mean ± SD, n = 6, 6, and 5 for unmodified, modified, and deacylated GCDH respectively; ∗ p -value ≤ 0.05). C , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and de-glutarylated ( light purple ) GCDH determined by using ETF/DCPIP as an electron acceptor and glutaryl-CoA as electron donor (mean ± SD, n = 4, 4, and 5 for unmodified, modified, and deacylated GCDH respectively, ∗ p -value ≤ 0.05). D and E , glutaryl-lysine sites identified by label-free quantitative LC-MS/MS on recombinant GCDH mapped to full-length human GCDH protein schematic with domain and residues important for cofactor, substrate, or tetramer interactions. Panel D shows glutaryl-lysine sites in chemically glutarylated GCDH sample expressed as a ratio over unmodified GCDH (glutarylation: glutarylated GCDH/unmodified). Panel E shows glutaryl-lysine sites on chemically glutarylated GCDH altered by SIRT5 incubation expressed as a ratio over glutarylated GCDH (deglutarylation: (glutarylated GCDH + SIRT5)/glutarylated GCDH). Plots representing Log 2 fold change (y-axis) and p -value (larger circle size = more significant p -value). F and G , homotetrameric structure of human GCDH with each subunit colored separately ( purple , blue , red , and green ). Yellow sticks indicate modified lysine residues. The FAD cofactor and CoA substrate are black and light gray spheres , respectively. H , far-UV CD spectra for glutarylated GCDH ( purple ) and unmodified GCDH ( black ) corrected for protein concentration (5 μM). I , thermal stability profiles for glutarylated GCDH ( open circles , purple curve ) and unmodified GCDH ( closed squares , dark curve ). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperatures were determined. J , immunoblot of native-PAGE separated GCDH tetramer and SDS-PAGE for denatured GCDH isolated from liver mitochondria of 24 h starved SIRT5WT and SIRT5KO mice. K , quantitation of GCDH tetramer intensity normalized to ETF complex intensity. Data representative of two independent experiments (mean ± SD, n = 3 for both SIRT5WT and SIRT5KO). ETF, electron transfer flavoprotein; GCDH, glutaryl-CoA dehydrogenase; SIRT5, sirtuin 5.
    Figure Legend Snippet: Glutarylation impairs GCDH activity and SIRT5 partially restores it. A , immunoblot of chemically modified GCDH (hGCDH-6xHIS) using glutaryl-CoA with or without incubation with recombinant SIRT5 (mSIRT5-6xHIS). Quantitative values of glutaryl-lysine intensity normalized to total protein are expressed as ratios relative to control (glutaryl-modified recombinant GCDH, lane 2). B , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and deglutarylated ( light purple ) GCDH determined by using PMS/DCPIP as artificial electron acceptors and glutaryl-CoA as electron donor (mean ± SD, n = 6, 6, and 5 for unmodified, modified, and deacylated GCDH respectively; ∗ p -value ≤ 0.05). C , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and de-glutarylated ( light purple ) GCDH determined by using ETF/DCPIP as an electron acceptor and glutaryl-CoA as electron donor (mean ± SD, n = 4, 4, and 5 for unmodified, modified, and deacylated GCDH respectively, ∗ p -value ≤ 0.05). D and E , glutaryl-lysine sites identified by label-free quantitative LC-MS/MS on recombinant GCDH mapped to full-length human GCDH protein schematic with domain and residues important for cofactor, substrate, or tetramer interactions. Panel D shows glutaryl-lysine sites in chemically glutarylated GCDH sample expressed as a ratio over unmodified GCDH (glutarylation: glutarylated GCDH/unmodified). Panel E shows glutaryl-lysine sites on chemically glutarylated GCDH altered by SIRT5 incubation expressed as a ratio over glutarylated GCDH (deglutarylation: (glutarylated GCDH + SIRT5)/glutarylated GCDH). Plots representing Log 2 fold change (y-axis) and p -value (larger circle size = more significant p -value). F and G , homotetrameric structure of human GCDH with each subunit colored separately ( purple , blue , red , and green ). Yellow sticks indicate modified lysine residues. The FAD cofactor and CoA substrate are black and light gray spheres , respectively. H , far-UV CD spectra for glutarylated GCDH ( purple ) and unmodified GCDH ( black ) corrected for protein concentration (5 μM). I , thermal stability profiles for glutarylated GCDH ( open circles , purple curve ) and unmodified GCDH ( closed squares , dark curve ). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperatures were determined. J , immunoblot of native-PAGE separated GCDH tetramer and SDS-PAGE for denatured GCDH isolated from liver mitochondria of 24 h starved SIRT5WT and SIRT5KO mice. K , quantitation of GCDH tetramer intensity normalized to ETF complex intensity. Data representative of two independent experiments (mean ± SD, n = 3 for both SIRT5WT and SIRT5KO). ETF, electron transfer flavoprotein; GCDH, glutaryl-CoA dehydrogenase; SIRT5, sirtuin 5.

    Techniques Used: Activity Assay, Western Blot, Modification, Incubation, Recombinant, Liquid Chromatography with Mass Spectroscopy, Protein Concentration, Clear Native PAGE, SDS Page, Isolation, Quantitation Assay

    SIRT5 ablation impairs lysine oxidation and glutaryl-CoA oxidation in cells and mice. A , schematic of lysine oxidation enzymes with steps that release carbon dioxide (CO 2 ). B , oxidation of [U- 14 C]-lysine to [ 14 C]-CO 2 in 293T SIRT5 crWT and crKO cells. Data representative of three independent experiments (mean ± SD, n = 6; ∗ p -value ≤ 0.05). C , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from 3 h starved 293T SIRT5 crWT and crKO cells. Data representative of single experiment (mean ± SD, n = 4; ∗ p -value ≤ 0.05). D , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from SIRT5WT and SIRT5KO mouse liver. Data representative of single experiment (mean ± SD, n = 6, 8 for SIRT5WT and SIRT5KO respectively; ∗ p -value ≤ 0.05). SIRT5, sirtuin 5.
    Figure Legend Snippet: SIRT5 ablation impairs lysine oxidation and glutaryl-CoA oxidation in cells and mice. A , schematic of lysine oxidation enzymes with steps that release carbon dioxide (CO 2 ). B , oxidation of [U- 14 C]-lysine to [ 14 C]-CO 2 in 293T SIRT5 crWT and crKO cells. Data representative of three independent experiments (mean ± SD, n = 6; ∗ p -value ≤ 0.05). C , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from 3 h starved 293T SIRT5 crWT and crKO cells. Data representative of single experiment (mean ± SD, n = 4; ∗ p -value ≤ 0.05). D , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from SIRT5WT and SIRT5KO mouse liver. Data representative of single experiment (mean ± SD, n = 6, 8 for SIRT5WT and SIRT5KO respectively; ∗ p -value ≤ 0.05). SIRT5, sirtuin 5.

    Techniques Used: Isolation

    glutaryl lysine  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc glutaryl lysine
    Characterization of <t>the</t> <t>SIRT5</t> crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " width="250" height="auto" />
    Glutaryl Lysine, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glutaryl lysine/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    glutaryl lysine - by Bioz Stars, 2023-03
    94/100 stars

    Images

    1) Product Images from "Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice"

    Article Title: Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice

    Journal: The Journal of Biological Chemistry

    doi: 10.1016/j.jbc.2022.101723

    Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " title="... and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA.

    Techniques Used: CRISPR, Western Blot

    Glutarylation-state of GCDH is regulated by Sirt5. A , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin or glutaryl-proteins by anti-glutaryl-lysine antibody (Glut-K) from HEK293T cells grown in complete media. Blots representative of at least three independent experiments. B , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or acylation media (DMEM without glucose, glutamine, pyruvate, 10% FBS). Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 2). C , immunoblot of immunopurified GCDH-FLAG by Flag-M2 resin from HEK293T cells grown in complete media with or without coexpressed SIRT5-HA. Blots representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG, lane 2). D , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or glutarylation media (EBSS containing 5 mM glucose, +50 mM Hepes, +0.8 mM lysine) with or without coexpressed SIRT5-HA. Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 1). E , immunoblot for pan-glutaryl lysine immunopurified proteins by endogenous GCDH and glutaryl-lysine from 3-month-old wild-type (SIRT5WT) and Sirt5 −/− (SIRT5KO) mice liver tissue that were refed or starved for 1 h following a 24 h starvation. Red arrow indicates the GCDH band within the glutaryl blot. Blots representative of at least three mice per group (n = 3 per group). F , relative quantification of the immunoblots in ( E ). Data representative of a single experiment from six SIRT5WT and six SIRT5KO mouse livers starved for 24 h from which half were refed (3 SIRT5WT and 3 SIRT5KO) normal diet for 1 h, while the remaining half (three SIRT5WT and three SIRT5KO) continued starvation for additional 1 h (mean ± SD, n = 3 per group). WT and Gcdh −/− (GCDHKO) mice (n = 1) were used as positive and negative controls, respectively, for identifying the correct GCDH band. One-way ANOVA followed by Tukey’s post hoc test was performed for multiple comparisons across groups where ∗ p -value = 0.0173, ∗∗ p -value = 0.0018, ∗∗∗ p -value = 0.0005, ∗∗∗∗ p -value < 0.0001. DMEM, Dulbecco’s modified Eagle’s medium; EBSS, Earle's Balanced Salt Solution; endo-SIRT5, endogenous SIRT5; FBS, fetal bovine serum; GCDH, glutaryl-CoA dehydrogenase.
    Figure Legend Snippet: Glutarylation-state of GCDH is regulated by Sirt5. A , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin or glutaryl-proteins by anti-glutaryl-lysine antibody (Glut-K) from HEK293T cells grown in complete media. Blots representative of at least three independent experiments. B , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or acylation media (DMEM without glucose, glutamine, pyruvate, 10% FBS). Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 2). C , immunoblot of immunopurified GCDH-FLAG by Flag-M2 resin from HEK293T cells grown in complete media with or without coexpressed SIRT5-HA. Blots representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG, lane 2). D , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or glutarylation media (EBSS containing 5 mM glucose, +50 mM Hepes, +0.8 mM lysine) with or without coexpressed SIRT5-HA. Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 1). E , immunoblot for pan-glutaryl lysine immunopurified proteins by endogenous GCDH and glutaryl-lysine from 3-month-old wild-type (SIRT5WT) and Sirt5 −/− (SIRT5KO) mice liver tissue that were refed or starved for 1 h following a 24 h starvation. Red arrow indicates the GCDH band within the glutaryl blot. Blots representative of at least three mice per group (n = 3 per group). F , relative quantification of the immunoblots in ( E ). Data representative of a single experiment from six SIRT5WT and six SIRT5KO mouse livers starved for 24 h from which half were refed (3 SIRT5WT and 3 SIRT5KO) normal diet for 1 h, while the remaining half (three SIRT5WT and three SIRT5KO) continued starvation for additional 1 h (mean ± SD, n = 3 per group). WT and Gcdh −/− (GCDHKO) mice (n = 1) were used as positive and negative controls, respectively, for identifying the correct GCDH band. One-way ANOVA followed by Tukey’s post hoc test was performed for multiple comparisons across groups where ∗ p -value = 0.0173, ∗∗ p -value = 0.0018, ∗∗∗ p -value = 0.0005, ∗∗∗∗ p -value < 0.0001. DMEM, Dulbecco’s modified Eagle’s medium; EBSS, Earle's Balanced Salt Solution; endo-SIRT5, endogenous SIRT5; FBS, fetal bovine serum; GCDH, glutaryl-CoA dehydrogenase.

    Techniques Used: Western Blot, Modification

    Glutarylation impairs GCDH activity and SIRT5 partially restores it. A , immunoblot of chemically modified GCDH (hGCDH-6xHIS) using glutaryl-CoA with or without incubation with recombinant SIRT5 (mSIRT5-6xHIS). Quantitative values of glutaryl-lysine intensity normalized to total protein are expressed as ratios relative to control (glutaryl-modified recombinant GCDH, lane 2). B , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and deglutarylated ( light purple ) GCDH determined by using PMS/DCPIP as artificial electron acceptors and glutaryl-CoA as electron donor (mean ± SD, n = 6, 6, and 5 for unmodified, modified, and deacylated GCDH respectively; ∗ p -value ≤ 0.05). C , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and de-glutarylated ( light purple ) GCDH determined by using ETF/DCPIP as an electron acceptor and glutaryl-CoA as electron donor (mean ± SD, n = 4, 4, and 5 for unmodified, modified, and deacylated GCDH respectively, ∗ p -value ≤ 0.05). D and E , glutaryl-lysine sites identified by label-free quantitative LC-MS/MS on recombinant GCDH mapped to full-length human GCDH protein schematic with domain and residues important for cofactor, substrate, or tetramer interactions. Panel D shows glutaryl-lysine sites in chemically glutarylated GCDH sample expressed as a ratio over unmodified GCDH (glutarylation: glutarylated GCDH/unmodified). Panel E shows glutaryl-lysine sites on chemically glutarylated GCDH altered by SIRT5 incubation expressed as a ratio over glutarylated GCDH (deglutarylation: (glutarylated GCDH + SIRT5)/glutarylated GCDH). Plots representing Log 2 fold change (y-axis) and p -value (larger circle size = more significant p -value). F and G , homotetrameric structure of human GCDH with each subunit colored separately ( purple , blue , red , and green ). Yellow sticks indicate modified lysine residues. The FAD cofactor and CoA substrate are black and light gray spheres , respectively. H , far-UV CD spectra for glutarylated GCDH ( purple ) and unmodified GCDH ( black ) corrected for protein concentration (5 μM). I , thermal stability profiles for glutarylated GCDH ( open circles , purple curve ) and unmodified GCDH ( closed squares , dark curve ). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperatures were determined. J , immunoblot of native-PAGE separated GCDH tetramer and SDS-PAGE for denatured GCDH isolated from liver mitochondria of 24 h starved SIRT5WT and SIRT5KO mice. K , quantitation of GCDH tetramer intensity normalized to ETF complex intensity. Data representative of two independent experiments (mean ± SD, n = 3 for both SIRT5WT and SIRT5KO). ETF, electron transfer flavoprotein; GCDH, glutaryl-CoA dehydrogenase; SIRT5, sirtuin 5.
    Figure Legend Snippet: Glutarylation impairs GCDH activity and SIRT5 partially restores it. A , immunoblot of chemically modified GCDH (hGCDH-6xHIS) using glutaryl-CoA with or without incubation with recombinant SIRT5 (mSIRT5-6xHIS). Quantitative values of glutaryl-lysine intensity normalized to total protein are expressed as ratios relative to control (glutaryl-modified recombinant GCDH, lane 2). B , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and deglutarylated ( light purple ) GCDH determined by using PMS/DCPIP as artificial electron acceptors and glutaryl-CoA as electron donor (mean ± SD, n = 6, 6, and 5 for unmodified, modified, and deacylated GCDH respectively; ∗ p -value ≤ 0.05). C , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and de-glutarylated ( light purple ) GCDH determined by using ETF/DCPIP as an electron acceptor and glutaryl-CoA as electron donor (mean ± SD, n = 4, 4, and 5 for unmodified, modified, and deacylated GCDH respectively, ∗ p -value ≤ 0.05). D and E , glutaryl-lysine sites identified by label-free quantitative LC-MS/MS on recombinant GCDH mapped to full-length human GCDH protein schematic with domain and residues important for cofactor, substrate, or tetramer interactions. Panel D shows glutaryl-lysine sites in chemically glutarylated GCDH sample expressed as a ratio over unmodified GCDH (glutarylation: glutarylated GCDH/unmodified). Panel E shows glutaryl-lysine sites on chemically glutarylated GCDH altered by SIRT5 incubation expressed as a ratio over glutarylated GCDH (deglutarylation: (glutarylated GCDH + SIRT5)/glutarylated GCDH). Plots representing Log 2 fold change (y-axis) and p -value (larger circle size = more significant p -value). F and G , homotetrameric structure of human GCDH with each subunit colored separately ( purple , blue , red , and green ). Yellow sticks indicate modified lysine residues. The FAD cofactor and CoA substrate are black and light gray spheres , respectively. H , far-UV CD spectra for glutarylated GCDH ( purple ) and unmodified GCDH ( black ) corrected for protein concentration (5 μM). I , thermal stability profiles for glutarylated GCDH ( open circles , purple curve ) and unmodified GCDH ( closed squares , dark curve ). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperatures were determined. J , immunoblot of native-PAGE separated GCDH tetramer and SDS-PAGE for denatured GCDH isolated from liver mitochondria of 24 h starved SIRT5WT and SIRT5KO mice. K , quantitation of GCDH tetramer intensity normalized to ETF complex intensity. Data representative of two independent experiments (mean ± SD, n = 3 for both SIRT5WT and SIRT5KO). ETF, electron transfer flavoprotein; GCDH, glutaryl-CoA dehydrogenase; SIRT5, sirtuin 5.

    Techniques Used: Activity Assay, Western Blot, Modification, Incubation, Recombinant, Liquid Chromatography with Mass Spectroscopy, Protein Concentration, Clear Native PAGE, SDS Page, Isolation, Quantitation Assay

    SIRT5 ablation impairs lysine oxidation and glutaryl-CoA oxidation in cells and mice. A , schematic of lysine oxidation enzymes with steps that release carbon dioxide (CO 2 ). B , oxidation of [U- 14 C]-lysine to [ 14 C]-CO 2 in 293T SIRT5 crWT and crKO cells. Data representative of three independent experiments (mean ± SD, n = 6; ∗ p -value ≤ 0.05). C , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from 3 h starved 293T SIRT5 crWT and crKO cells. Data representative of single experiment (mean ± SD, n = 4; ∗ p -value ≤ 0.05). D , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from SIRT5WT and SIRT5KO mouse liver. Data representative of single experiment (mean ± SD, n = 6, 8 for SIRT5WT and SIRT5KO respectively; ∗ p -value ≤ 0.05). SIRT5, sirtuin 5.
    Figure Legend Snippet: SIRT5 ablation impairs lysine oxidation and glutaryl-CoA oxidation in cells and mice. A , schematic of lysine oxidation enzymes with steps that release carbon dioxide (CO 2 ). B , oxidation of [U- 14 C]-lysine to [ 14 C]-CO 2 in 293T SIRT5 crWT and crKO cells. Data representative of three independent experiments (mean ± SD, n = 6; ∗ p -value ≤ 0.05). C , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from 3 h starved 293T SIRT5 crWT and crKO cells. Data representative of single experiment (mean ± SD, n = 4; ∗ p -value ≤ 0.05). D , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from SIRT5WT and SIRT5KO mouse liver. Data representative of single experiment (mean ± SD, n = 6, 8 for SIRT5WT and SIRT5KO respectively; ∗ p -value ≤ 0.05). SIRT5, sirtuin 5.

    Techniques Used: Isolation

    ptmscan pan glutaryl lysine affinity resin  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc ptmscan pan glutaryl lysine affinity resin
    Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " width="250" height="auto" />
    Ptmscan Pan Glutaryl Lysine Affinity Resin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ptmscan pan glutaryl lysine affinity resin/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ptmscan pan glutaryl lysine affinity resin - by Bioz Stars, 2023-03
    94/100 stars

    Images

    1) Product Images from "Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice"

    Article Title: Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice

    Journal: The Journal of Biological Chemistry

    doi: 10.1016/j.jbc.2022.101723

    Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " title="... and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA.

    Techniques Used: CRISPR, Western Blot

    Glutarylation-state of GCDH is regulated by Sirt5. A , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin or glutaryl-proteins by anti-glutaryl-lysine antibody (Glut-K) from HEK293T cells grown in complete media. Blots representative of at least three independent experiments. B , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or acylation media (DMEM without glucose, glutamine, pyruvate, 10% FBS). Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 2). C , immunoblot of immunopurified GCDH-FLAG by Flag-M2 resin from HEK293T cells grown in complete media with or without coexpressed SIRT5-HA. Blots representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG, lane 2). D , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or glutarylation media (EBSS containing 5 mM glucose, +50 mM Hepes, +0.8 mM lysine) with or without coexpressed SIRT5-HA. Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 1). E , immunoblot for pan-glutaryl lysine immunopurified proteins by endogenous GCDH and glutaryl-lysine from 3-month-old wild-type (SIRT5WT) and Sirt5 −/− (SIRT5KO) mice liver tissue that were refed or starved for 1 h following a 24 h starvation. Red arrow indicates the GCDH band within the glutaryl blot. Blots representative of at least three mice per group (n = 3 per group). F , relative quantification of the immunoblots in ( E ). Data representative of a single experiment from six SIRT5WT and six SIRT5KO mouse livers starved for 24 h from which half were refed (3 SIRT5WT and 3 SIRT5KO) normal diet for 1 h, while the remaining half (three SIRT5WT and three SIRT5KO) continued starvation for additional 1 h (mean ± SD, n = 3 per group). WT and Gcdh −/− (GCDHKO) mice (n = 1) were used as positive and negative controls, respectively, for identifying the correct GCDH band. One-way ANOVA followed by Tukey’s post hoc test was performed for multiple comparisons across groups where ∗ p -value = 0.0173, ∗∗ p -value = 0.0018, ∗∗∗ p -value = 0.0005, ∗∗∗∗ p -value < 0.0001. DMEM, Dulbecco’s modified Eagle’s medium; EBSS, Earle's Balanced Salt Solution; endo-SIRT5, endogenous SIRT5; FBS, fetal bovine serum; GCDH, glutaryl-CoA dehydrogenase.
    Figure Legend Snippet: Glutarylation-state of GCDH is regulated by Sirt5. A , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin or glutaryl-proteins by anti-glutaryl-lysine antibody (Glut-K) from HEK293T cells grown in complete media. Blots representative of at least three independent experiments. B , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or acylation media (DMEM without glucose, glutamine, pyruvate, 10% FBS). Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 2). C , immunoblot of immunopurified GCDH-FLAG by Flag-M2 resin from HEK293T cells grown in complete media with or without coexpressed SIRT5-HA. Blots representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG, lane 2). D , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or glutarylation media (EBSS containing 5 mM glucose, +50 mM Hepes, +0.8 mM lysine) with or without coexpressed SIRT5-HA. Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 1). E , immunoblot for pan-glutaryl lysine immunopurified proteins by endogenous GCDH and glutaryl-lysine from 3-month-old wild-type (SIRT5WT) and Sirt5 −/− (SIRT5KO) mice liver tissue that were refed or starved for 1 h following a 24 h starvation. Red arrow indicates the GCDH band within the glutaryl blot. Blots representative of at least three mice per group (n = 3 per group). F , relative quantification of the immunoblots in ( E ). Data representative of a single experiment from six SIRT5WT and six SIRT5KO mouse livers starved for 24 h from which half were refed (3 SIRT5WT and 3 SIRT5KO) normal diet for 1 h, while the remaining half (three SIRT5WT and three SIRT5KO) continued starvation for additional 1 h (mean ± SD, n = 3 per group). WT and Gcdh −/− (GCDHKO) mice (n = 1) were used as positive and negative controls, respectively, for identifying the correct GCDH band. One-way ANOVA followed by Tukey’s post hoc test was performed for multiple comparisons across groups where ∗ p -value = 0.0173, ∗∗ p -value = 0.0018, ∗∗∗ p -value = 0.0005, ∗∗∗∗ p -value < 0.0001. DMEM, Dulbecco’s modified Eagle’s medium; EBSS, Earle's Balanced Salt Solution; endo-SIRT5, endogenous SIRT5; FBS, fetal bovine serum; GCDH, glutaryl-CoA dehydrogenase.

    Techniques Used: Western Blot, Modification

    Glutarylation impairs GCDH activity and SIRT5 partially restores it. A , immunoblot of chemically modified GCDH (hGCDH-6xHIS) using glutaryl-CoA with or without incubation with recombinant SIRT5 (mSIRT5-6xHIS). Quantitative values of glutaryl-lysine intensity normalized to total protein are expressed as ratios relative to control (glutaryl-modified recombinant GCDH, lane 2). B , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and deglutarylated ( light purple ) GCDH determined by using PMS/DCPIP as artificial electron acceptors and glutaryl-CoA as electron donor (mean ± SD, n = 6, 6, and 5 for unmodified, modified, and deacylated GCDH respectively; ∗ p -value ≤ 0.05). C , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and de-glutarylated ( light purple ) GCDH determined by using ETF/DCPIP as an electron acceptor and glutaryl-CoA as electron donor (mean ± SD, n = 4, 4, and 5 for unmodified, modified, and deacylated GCDH respectively, ∗ p -value ≤ 0.05). D and E , glutaryl-lysine sites identified by label-free quantitative LC-MS/MS on recombinant GCDH mapped to full-length human GCDH protein schematic with domain and residues important for cofactor, substrate, or tetramer interactions. Panel D shows glutaryl-lysine sites in chemically glutarylated GCDH sample expressed as a ratio over unmodified GCDH (glutarylation: glutarylated GCDH/unmodified). Panel E shows glutaryl-lysine sites on chemically glutarylated GCDH altered by SIRT5 incubation expressed as a ratio over glutarylated GCDH (deglutarylation: (glutarylated GCDH + SIRT5)/glutarylated GCDH). Plots representing Log 2 fold change (y-axis) and p -value (larger circle size = more significant p -value). F and G , homotetrameric structure of human GCDH with each subunit colored separately ( purple , blue , red , and green ). Yellow sticks indicate modified lysine residues. The FAD cofactor and CoA substrate are black and light gray spheres , respectively. H , far-UV CD spectra for glutarylated GCDH ( purple ) and unmodified GCDH ( black ) corrected for protein concentration (5 μM). I , thermal stability profiles for glutarylated GCDH ( open circles , purple curve ) and unmodified GCDH ( closed squares , dark curve ). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperatures were determined. J , immunoblot of native-PAGE separated GCDH tetramer and SDS-PAGE for denatured GCDH isolated from liver mitochondria of 24 h starved SIRT5WT and SIRT5KO mice. K , quantitation of GCDH tetramer intensity normalized to ETF complex intensity. Data representative of two independent experiments (mean ± SD, n = 3 for both SIRT5WT and SIRT5KO). ETF, electron transfer flavoprotein; GCDH, glutaryl-CoA dehydrogenase; SIRT5, sirtuin 5.
    Figure Legend Snippet: Glutarylation impairs GCDH activity and SIRT5 partially restores it. A , immunoblot of chemically modified GCDH (hGCDH-6xHIS) using glutaryl-CoA with or without incubation with recombinant SIRT5 (mSIRT5-6xHIS). Quantitative values of glutaryl-lysine intensity normalized to total protein are expressed as ratios relative to control (glutaryl-modified recombinant GCDH, lane 2). B , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and deglutarylated ( light purple ) GCDH determined by using PMS/DCPIP as artificial electron acceptors and glutaryl-CoA as electron donor (mean ± SD, n = 6, 6, and 5 for unmodified, modified, and deacylated GCDH respectively; ∗ p -value ≤ 0.05). C , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and de-glutarylated ( light purple ) GCDH determined by using ETF/DCPIP as an electron acceptor and glutaryl-CoA as electron donor (mean ± SD, n = 4, 4, and 5 for unmodified, modified, and deacylated GCDH respectively, ∗ p -value ≤ 0.05). D and E , glutaryl-lysine sites identified by label-free quantitative LC-MS/MS on recombinant GCDH mapped to full-length human GCDH protein schematic with domain and residues important for cofactor, substrate, or tetramer interactions. Panel D shows glutaryl-lysine sites in chemically glutarylated GCDH sample expressed as a ratio over unmodified GCDH (glutarylation: glutarylated GCDH/unmodified). Panel E shows glutaryl-lysine sites on chemically glutarylated GCDH altered by SIRT5 incubation expressed as a ratio over glutarylated GCDH (deglutarylation: (glutarylated GCDH + SIRT5)/glutarylated GCDH). Plots representing Log 2 fold change (y-axis) and p -value (larger circle size = more significant p -value). F and G , homotetrameric structure of human GCDH with each subunit colored separately ( purple , blue , red , and green ). Yellow sticks indicate modified lysine residues. The FAD cofactor and CoA substrate are black and light gray spheres , respectively. H , far-UV CD spectra for glutarylated GCDH ( purple ) and unmodified GCDH ( black ) corrected for protein concentration (5 μM). I , thermal stability profiles for glutarylated GCDH ( open circles , purple curve ) and unmodified GCDH ( closed squares , dark curve ). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperatures were determined. J , immunoblot of native-PAGE separated GCDH tetramer and SDS-PAGE for denatured GCDH isolated from liver mitochondria of 24 h starved SIRT5WT and SIRT5KO mice. K , quantitation of GCDH tetramer intensity normalized to ETF complex intensity. Data representative of two independent experiments (mean ± SD, n = 3 for both SIRT5WT and SIRT5KO). ETF, electron transfer flavoprotein; GCDH, glutaryl-CoA dehydrogenase; SIRT5, sirtuin 5.

    Techniques Used: Activity Assay, Western Blot, Modification, Incubation, Recombinant, Liquid Chromatography with Mass Spectroscopy, Protein Concentration, Clear Native PAGE, SDS Page, Isolation, Quantitation Assay

    SIRT5 ablation impairs lysine oxidation and glutaryl-CoA oxidation in cells and mice. A , schematic of lysine oxidation enzymes with steps that release carbon dioxide (CO 2 ). B , oxidation of [U- 14 C]-lysine to [ 14 C]-CO 2 in 293T SIRT5 crWT and crKO cells. Data representative of three independent experiments (mean ± SD, n = 6; ∗ p -value ≤ 0.05). C , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from 3 h starved 293T SIRT5 crWT and crKO cells. Data representative of single experiment (mean ± SD, n = 4; ∗ p -value ≤ 0.05). D , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from SIRT5WT and SIRT5KO mouse liver. Data representative of single experiment (mean ± SD, n = 6, 8 for SIRT5WT and SIRT5KO respectively; ∗ p -value ≤ 0.05). SIRT5, sirtuin 5.
    Figure Legend Snippet: SIRT5 ablation impairs lysine oxidation and glutaryl-CoA oxidation in cells and mice. A , schematic of lysine oxidation enzymes with steps that release carbon dioxide (CO 2 ). B , oxidation of [U- 14 C]-lysine to [ 14 C]-CO 2 in 293T SIRT5 crWT and crKO cells. Data representative of three independent experiments (mean ± SD, n = 6; ∗ p -value ≤ 0.05). C , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from 3 h starved 293T SIRT5 crWT and crKO cells. Data representative of single experiment (mean ± SD, n = 4; ∗ p -value ≤ 0.05). D , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from SIRT5WT and SIRT5KO mouse liver. Data representative of single experiment (mean ± SD, n = 6, 8 for SIRT5WT and SIRT5KO respectively; ∗ p -value ≤ 0.05). SIRT5, sirtuin 5.

    Techniques Used: Isolation

    anti glutaryl lysine  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc anti glutaryl lysine
    Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " width="250" height="auto" />
    Anti Glutaryl Lysine, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti glutaryl lysine/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti glutaryl lysine - by Bioz Stars, 2023-03
    86/100 stars

    Images

    1) Product Images from "Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice"

    Article Title: Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice

    Journal: The Journal of Biological Chemistry

    doi: 10.1016/j.jbc.2022.101723

    Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " title="... and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA.

    Techniques Used: CRISPR, Western Blot

    14943mf  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc 14943mf
    14943mf, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/14943mf/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    14943mf - by Bioz Stars, 2023-03
    94/100 stars

    Images

    glucose transporter glut2  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc glucose transporter glut2
    Glucose Transporter Glut2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glucose transporter glut2/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    glucose transporter glut2 - by Bioz Stars, 2023-03
    94/100 stars

    Images

    pan glutaryl lysine ptm 1151  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc pan glutaryl lysine ptm 1151
    Pan Glutaryl Lysine Ptm 1151, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pan glutaryl lysine ptm 1151/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pan glutaryl lysine ptm 1151 - by Bioz Stars, 2023-03
    86/100 stars

    Images

    anti glutaryl lysine  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc anti glutaryl lysine
    (A) Immunoblot for SIRT5 protein from HEK293T crWT (circles) clone, and crKO (blank) clone (using CRISPR guide E, table S1). (B) Relative SIRT5 protein quantification of (A) (mean ± SD, n=3). (C) Relative mRNA expression of mitochondrial sirtuins (SIRT3, 4 and 5) normalized to ATP subunit 5 mRNA levels in 293T SIRT5 crWT and crKO cells (mean ± SEM, n=5, *= p-value ≤ 0.05). (D-G) Immunoblots of SIRT5 crWT and crKO whole cell lysates blotted using antibodies against <t>glutaryl-lysine</t> (D), -succinyl-lysine (E), malonyl-lysine (F), and acetyl-lysine (G). (H-K) Relative quantification of acylated proteins normalized <t>to</t> <t>β-actin</t> levels: glutarylation (H), succinylation (I), malonylation (J), and acetylation (K) (mean ± SD, n=3).
    Anti Glutaryl Lysine, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti glutaryl lysine/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti glutaryl lysine - by Bioz Stars, 2023-03
    86/100 stars

    Images

    1) Product Images from "Deglutarylation of GCDH by SIRT5 controls lysine metabolism in mice"

    Article Title: Deglutarylation of GCDH by SIRT5 controls lysine metabolism in mice

    Journal: bioRxiv

    doi: 10.1101/2020.06.28.176677

    (A) Immunoblot for SIRT5 protein from HEK293T crWT (circles) clone, and crKO (blank) clone (using CRISPR guide E, table S1). (B) Relative SIRT5 protein quantification of (A) (mean ± SD, n=3). (C) Relative mRNA expression of mitochondrial sirtuins (SIRT3, 4 and 5) normalized to ATP subunit 5 mRNA levels in 293T SIRT5 crWT and crKO cells (mean ± SEM, n=5, *= p-value ≤ 0.05). (D-G) Immunoblots of SIRT5 crWT and crKO whole cell lysates blotted using antibodies against glutaryl-lysine (D), -succinyl-lysine (E), malonyl-lysine (F), and acetyl-lysine (G). (H-K) Relative quantification of acylated proteins normalized to β-actin levels: glutarylation (H), succinylation (I), malonylation (J), and acetylation (K) (mean ± SD, n=3).
    Figure Legend Snippet: (A) Immunoblot for SIRT5 protein from HEK293T crWT (circles) clone, and crKO (blank) clone (using CRISPR guide E, table S1). (B) Relative SIRT5 protein quantification of (A) (mean ± SD, n=3). (C) Relative mRNA expression of mitochondrial sirtuins (SIRT3, 4 and 5) normalized to ATP subunit 5 mRNA levels in 293T SIRT5 crWT and crKO cells (mean ± SEM, n=5, *= p-value ≤ 0.05). (D-G) Immunoblots of SIRT5 crWT and crKO whole cell lysates blotted using antibodies against glutaryl-lysine (D), -succinyl-lysine (E), malonyl-lysine (F), and acetyl-lysine (G). (H-K) Relative quantification of acylated proteins normalized to β-actin levels: glutarylation (H), succinylation (I), malonylation (J), and acetylation (K) (mean ± SD, n=3).

    Techniques Used: Western Blot, CRISPR, Expressing

    (A) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin from 293T SIRT5 crWT or crKO cells grown in complete media or acylation media (DMEM - glucose, - glutamine, - pyruvate, + 10% FBS). Blots are representative of at least three independent experiments and quantitative values of succinyl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 2. Same experiment as , blotted for Succ-K). (B) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or glutarylation media (EBSS +50mM HEPES, +0.8mM Lysine) with or without co-expressed SIRT5-HA. Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 1. Same experiment as , blotted for Succ-K). (C) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin or succinyl-proteins by anti-succinyl-lysine antibody (Succ-K) from 293T SIRT5 CRISPR cells grown in complete media media. Blots representative of at least three independent experiments. (D) Immunoblot of immuno-purified GCDH-FLAG by Flag-M2 resin from 293T SIRT5 CRISPR cells grown in complete media with or without co-expressed SIRT5-HA. Blots representative of at least three independent experiments and quantitative values of succinyl-lysine intensity normalized to FLAG intensity expressed as rations relative to control (overexpressed GCDH-FLAG, lane 2. Same experiment as , blotted for Succ-K) (E) Immunoblot of chemically modified GCDH (hGCDH-6xHIS) using succinyl-CoA with or without incubation with recombinant SIRT5 (mSIRT5-6xHIS). Quantitative values of succinyl-lysine intensity normalized to total protein are expressed as ratios relative to control (succinyl-modified recombinant GCDH, lane 2) (F) Enzymatic activity of unmodified (black), succinylated (dark green) and desuccinylated (bright green) GCDH determined by using PMS/DCPIP as artificial electron acceptors and Succinyl-CoA as electron donor (mean ± SD, n=6, 8, and 7 for unmodified, modified and deacylated GCDH respectively; * = p-value ≤ 0.05). (G) Succinyl-K sites as identified by label-free quantitative LC-MS/MS on recombinant GCDH are mapped on full-length human GCDH protein.
    Figure Legend Snippet: (A) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin from 293T SIRT5 crWT or crKO cells grown in complete media or acylation media (DMEM - glucose, - glutamine, - pyruvate, + 10% FBS). Blots are representative of at least three independent experiments and quantitative values of succinyl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 2. Same experiment as , blotted for Succ-K). (B) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or glutarylation media (EBSS +50mM HEPES, +0.8mM Lysine) with or without co-expressed SIRT5-HA. Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 1. Same experiment as , blotted for Succ-K). (C) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin or succinyl-proteins by anti-succinyl-lysine antibody (Succ-K) from 293T SIRT5 CRISPR cells grown in complete media media. Blots representative of at least three independent experiments. (D) Immunoblot of immuno-purified GCDH-FLAG by Flag-M2 resin from 293T SIRT5 CRISPR cells grown in complete media with or without co-expressed SIRT5-HA. Blots representative of at least three independent experiments and quantitative values of succinyl-lysine intensity normalized to FLAG intensity expressed as rations relative to control (overexpressed GCDH-FLAG, lane 2. Same experiment as , blotted for Succ-K) (E) Immunoblot of chemically modified GCDH (hGCDH-6xHIS) using succinyl-CoA with or without incubation with recombinant SIRT5 (mSIRT5-6xHIS). Quantitative values of succinyl-lysine intensity normalized to total protein are expressed as ratios relative to control (succinyl-modified recombinant GCDH, lane 2) (F) Enzymatic activity of unmodified (black), succinylated (dark green) and desuccinylated (bright green) GCDH determined by using PMS/DCPIP as artificial electron acceptors and Succinyl-CoA as electron donor (mean ± SD, n=6, 8, and 7 for unmodified, modified and deacylated GCDH respectively; * = p-value ≤ 0.05). (G) Succinyl-K sites as identified by label-free quantitative LC-MS/MS on recombinant GCDH are mapped on full-length human GCDH protein.

    Techniques Used: Western Blot, Purification, CRISPR, Modification, Incubation, Recombinant, Activity Assay, Liquid Chromatography with Mass Spectroscopy

    (A) Enzymatic activity of unmodified (black), glutarylated (dark purple) and de-glutarylated (light purple) GCDH determined by using ETF/DCPIP as an electron acceptors and Glutaryl-CoA as electron donor (mean ± SD, n = 4, 4, and 5 for unmodified, modified and deacylated GCDH respectively, *: p-value ≤ 0.05). (B) Enzymatic activity of unmodified (black), succinylated (dark green) and de-succinylated (light green) GCDH determined by using ETF/DCPIP as an electron acceptors and Succinyl-CoA as electron donor (mean ± SD, n = 4, 4, and 3 for unmodified, modified and deacylated GCDH respectively, *: p-value ≤ 0.05). (C) Immunoblot of blue-native PAGE separated GCDH tetramer and SDS-PAGE for denatured GCDH isolated from liver mitochondria of 24 h fed SIRT5WT and SIRT5KO mice. Fed GCDHKO mouse liver mitochondrial lysates used as control to identify correct GCDH tetramer complex. (D-E) Homotetrameric structure of human GCDH with each subunit colored separately (purple, blue, red, and green). Yellow sticks indicate modified lysine residues. The FAD cofactor and CoA substrate are black and light gray spheres, respectively. (F) Quantitation of GCDH tetramer intensity normalized to ETF complex intensity. Data representative of two independent experiments (mean ± SD, n = 3 for both SIRT5 WT and SIRT5 KO). (G) Far-UV CD spectra for glutarylated-GCDH (purple) and unmodified GCDH (black). (H) Thermal stability profiles for glutarylated-GCDH (open circles, purple curve) and unmodified GCDH (closed squares, dark curve). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperature were determined. (I) Far-UV CD spectra for succinylated-GCDH (green) and unmodified GCDH (black). (J) Thermal stability profiles for succinylated-GCDH (open circles, green curve) and unmodified GCDH (closed squares, green curve). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperature was determined.
    Figure Legend Snippet: (A) Enzymatic activity of unmodified (black), glutarylated (dark purple) and de-glutarylated (light purple) GCDH determined by using ETF/DCPIP as an electron acceptors and Glutaryl-CoA as electron donor (mean ± SD, n = 4, 4, and 5 for unmodified, modified and deacylated GCDH respectively, *: p-value ≤ 0.05). (B) Enzymatic activity of unmodified (black), succinylated (dark green) and de-succinylated (light green) GCDH determined by using ETF/DCPIP as an electron acceptors and Succinyl-CoA as electron donor (mean ± SD, n = 4, 4, and 3 for unmodified, modified and deacylated GCDH respectively, *: p-value ≤ 0.05). (C) Immunoblot of blue-native PAGE separated GCDH tetramer and SDS-PAGE for denatured GCDH isolated from liver mitochondria of 24 h fed SIRT5WT and SIRT5KO mice. Fed GCDHKO mouse liver mitochondrial lysates used as control to identify correct GCDH tetramer complex. (D-E) Homotetrameric structure of human GCDH with each subunit colored separately (purple, blue, red, and green). Yellow sticks indicate modified lysine residues. The FAD cofactor and CoA substrate are black and light gray spheres, respectively. (F) Quantitation of GCDH tetramer intensity normalized to ETF complex intensity. Data representative of two independent experiments (mean ± SD, n = 3 for both SIRT5 WT and SIRT5 KO). (G) Far-UV CD spectra for glutarylated-GCDH (purple) and unmodified GCDH (black). (H) Thermal stability profiles for glutarylated-GCDH (open circles, purple curve) and unmodified GCDH (closed squares, dark curve). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperature were determined. (I) Far-UV CD spectra for succinylated-GCDH (green) and unmodified GCDH (black). (J) Thermal stability profiles for succinylated-GCDH (open circles, green curve) and unmodified GCDH (closed squares, green curve). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperature was determined.

    Techniques Used: Activity Assay, Modification, Western Blot, Blue Native PAGE, SDS Page, Isolation, Quantitation Assay

    glutaryl lysine  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc glutaryl lysine
    (A) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin or <t>glutaryl-proteins</t> by anti-glutaryl-lysine antibody (Glut-K) from HEK293T cells grown in complete media. Blots representative of at least three independent experiments. (B) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin <t>from</t> <t>SIRT5</t> crWT or crKO cells grown in complete media or acylation media (DMEM - glucose, - glutamine, - pyruvate, - 10% FBS). Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 2). (C) Immunoblot of immuno-purified GCDH-FLAG by Flag-M2 resin from HEK293T cells grown in complete media with or without co-expressed SIRT5-HA. Blots representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as rations relative to control (overexpressed GCDH-FLAG, lane 2) (D) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or glutarylation media (EBSS +5mM glucose, +50mM HEPES, +0.8mM Lysine) with or without co-expressed SIRT5-HA. Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 1) (E) Immunoblot of chemically modified GCDH (hGCDH-6xHIS) using glutaryl-CoA with or without incubation with recombinant SIRT5 (mSIRT5-6xHIS). Quantitative values of glutaryl-lysine intensity normalized to total protein are expressed as ratios relative to control (glutaryl-modified recombinant GCDH, lane 2) (F) Enzymatic activity of unmodified (black), glutarylated (dark purple) and deglutarylated (light purple) GCDH determined by using PMS/DCPIP as artificial electron acceptors and Glutaryl-CoA as electron donor (mean ± SD, n=6, 6, and 5 for unmodified, modified and deacylated GCDH respectively; * = p-value ≤ 0.05). (GH) Glutaryl- lysine sites identified by label-free quantitative LC-MS/MS on recombinant GCDH mapped to full-length human GCDH protein schematic with domain and residues important for cofactor, substrate, or tetramer interactions. Panel G shows glutaryl-lysine sites in chemically glutarylated GCDH sample expressed as ratio over unmodified GCDH (Glutarylation: glutarylated GCDH/unmodified). Pael H shows glutaryl-lysine sites on chemically glutarylated GCDH altered by SIRT5 incubation as expressed as a ration over glutarylated sample(Deglutarylation: glutarylated GCDH + SIRT5/glutarylated GCDH), Plots representing Log 2 fold change (y-axis) and p-value (larger circle size = more significant p-value).
    Glutaryl Lysine, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glutaryl lysine/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    glutaryl lysine - by Bioz Stars, 2023-03
    86/100 stars

    Images

    1) Product Images from "Deglutarylation of GCDH by SIRT5 controls lysine metabolism in mice"

    Article Title: Deglutarylation of GCDH by SIRT5 controls lysine metabolism in mice

    Journal: bioRxiv

    doi: 10.1101/2020.06.28.176677

    (A) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin or glutaryl-proteins by anti-glutaryl-lysine antibody (Glut-K) from HEK293T cells grown in complete media. Blots representative of at least three independent experiments. (B) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or acylation media (DMEM - glucose, - glutamine, - pyruvate, - 10% FBS). Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 2). (C) Immunoblot of immuno-purified GCDH-FLAG by Flag-M2 resin from HEK293T cells grown in complete media with or without co-expressed SIRT5-HA. Blots representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as rations relative to control (overexpressed GCDH-FLAG, lane 2) (D) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or glutarylation media (EBSS +5mM glucose, +50mM HEPES, +0.8mM Lysine) with or without co-expressed SIRT5-HA. Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 1) (E) Immunoblot of chemically modified GCDH (hGCDH-6xHIS) using glutaryl-CoA with or without incubation with recombinant SIRT5 (mSIRT5-6xHIS). Quantitative values of glutaryl-lysine intensity normalized to total protein are expressed as ratios relative to control (glutaryl-modified recombinant GCDH, lane 2) (F) Enzymatic activity of unmodified (black), glutarylated (dark purple) and deglutarylated (light purple) GCDH determined by using PMS/DCPIP as artificial electron acceptors and Glutaryl-CoA as electron donor (mean ± SD, n=6, 6, and 5 for unmodified, modified and deacylated GCDH respectively; * = p-value ≤ 0.05). (GH) Glutaryl- lysine sites identified by label-free quantitative LC-MS/MS on recombinant GCDH mapped to full-length human GCDH protein schematic with domain and residues important for cofactor, substrate, or tetramer interactions. Panel G shows glutaryl-lysine sites in chemically glutarylated GCDH sample expressed as ratio over unmodified GCDH (Glutarylation: glutarylated GCDH/unmodified). Pael H shows glutaryl-lysine sites on chemically glutarylated GCDH altered by SIRT5 incubation as expressed as a ration over glutarylated sample(Deglutarylation: glutarylated GCDH + SIRT5/glutarylated GCDH), Plots representing Log 2 fold change (y-axis) and p-value (larger circle size = more significant p-value).
    Figure Legend Snippet: (A) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin or glutaryl-proteins by anti-glutaryl-lysine antibody (Glut-K) from HEK293T cells grown in complete media. Blots representative of at least three independent experiments. (B) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or acylation media (DMEM - glucose, - glutamine, - pyruvate, - 10% FBS). Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 2). (C) Immunoblot of immuno-purified GCDH-FLAG by Flag-M2 resin from HEK293T cells grown in complete media with or without co-expressed SIRT5-HA. Blots representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as rations relative to control (overexpressed GCDH-FLAG, lane 2) (D) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or glutarylation media (EBSS +5mM glucose, +50mM HEPES, +0.8mM Lysine) with or without co-expressed SIRT5-HA. Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 1) (E) Immunoblot of chemically modified GCDH (hGCDH-6xHIS) using glutaryl-CoA with or without incubation with recombinant SIRT5 (mSIRT5-6xHIS). Quantitative values of glutaryl-lysine intensity normalized to total protein are expressed as ratios relative to control (glutaryl-modified recombinant GCDH, lane 2) (F) Enzymatic activity of unmodified (black), glutarylated (dark purple) and deglutarylated (light purple) GCDH determined by using PMS/DCPIP as artificial electron acceptors and Glutaryl-CoA as electron donor (mean ± SD, n=6, 6, and 5 for unmodified, modified and deacylated GCDH respectively; * = p-value ≤ 0.05). (GH) Glutaryl- lysine sites identified by label-free quantitative LC-MS/MS on recombinant GCDH mapped to full-length human GCDH protein schematic with domain and residues important for cofactor, substrate, or tetramer interactions. Panel G shows glutaryl-lysine sites in chemically glutarylated GCDH sample expressed as ratio over unmodified GCDH (Glutarylation: glutarylated GCDH/unmodified). Pael H shows glutaryl-lysine sites on chemically glutarylated GCDH altered by SIRT5 incubation as expressed as a ration over glutarylated sample(Deglutarylation: glutarylated GCDH + SIRT5/glutarylated GCDH), Plots representing Log 2 fold change (y-axis) and p-value (larger circle size = more significant p-value).

    Techniques Used: Western Blot, Purification, Modification, Incubation, Recombinant, Activity Assay, Liquid Chromatography with Mass Spectroscopy

    (A) Immunoblot for SIRT5 protein from HEK293T crWT (circles) clone, and crKO (blank) clone (using CRISPR guide E, table S1). (B) Relative SIRT5 protein quantification of (A) (mean ± SD, n=3). (C) Relative mRNA expression of mitochondrial sirtuins (SIRT3, 4 and 5) normalized to ATP subunit 5 mRNA levels in 293T SIRT5 crWT and crKO cells (mean ± SEM, n=5, *= p-value ≤ 0.05). (D-G) Immunoblots of SIRT5 crWT and crKO whole cell lysates blotted using antibodies against glutaryl-lysine (D), -succinyl-lysine (E), malonyl-lysine (F), and acetyl-lysine (G). (H-K) Relative quantification of acylated proteins normalized to β-actin levels: glutarylation (H), succinylation (I), malonylation (J), and acetylation (K) (mean ± SD, n=3).
    Figure Legend Snippet: (A) Immunoblot for SIRT5 protein from HEK293T crWT (circles) clone, and crKO (blank) clone (using CRISPR guide E, table S1). (B) Relative SIRT5 protein quantification of (A) (mean ± SD, n=3). (C) Relative mRNA expression of mitochondrial sirtuins (SIRT3, 4 and 5) normalized to ATP subunit 5 mRNA levels in 293T SIRT5 crWT and crKO cells (mean ± SEM, n=5, *= p-value ≤ 0.05). (D-G) Immunoblots of SIRT5 crWT and crKO whole cell lysates blotted using antibodies against glutaryl-lysine (D), -succinyl-lysine (E), malonyl-lysine (F), and acetyl-lysine (G). (H-K) Relative quantification of acylated proteins normalized to β-actin levels: glutarylation (H), succinylation (I), malonylation (J), and acetylation (K) (mean ± SD, n=3).

    Techniques Used: Western Blot, CRISPR, Expressing

    (A) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin from 293T SIRT5 crWT or crKO cells grown in complete media or acylation media (DMEM - glucose, - glutamine, - pyruvate, + 10% FBS). Blots are representative of at least three independent experiments and quantitative values of succinyl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 2. Same experiment as , blotted for Succ-K). (B) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or glutarylation media (EBSS +50mM HEPES, +0.8mM Lysine) with or without co-expressed SIRT5-HA. Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 1. Same experiment as , blotted for Succ-K). (C) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin or succinyl-proteins by anti-succinyl-lysine antibody (Succ-K) from 293T SIRT5 CRISPR cells grown in complete media media. Blots representative of at least three independent experiments. (D) Immunoblot of immuno-purified GCDH-FLAG by Flag-M2 resin from 293T SIRT5 CRISPR cells grown in complete media with or without co-expressed SIRT5-HA. Blots representative of at least three independent experiments and quantitative values of succinyl-lysine intensity normalized to FLAG intensity expressed as rations relative to control (overexpressed GCDH-FLAG, lane 2. Same experiment as , blotted for Succ-K) (E) Immunoblot of chemically modified GCDH (hGCDH-6xHIS) using succinyl-CoA with or without incubation with recombinant SIRT5 (mSIRT5-6xHIS). Quantitative values of succinyl-lysine intensity normalized to total protein are expressed as ratios relative to control (succinyl-modified recombinant GCDH, lane 2) (F) Enzymatic activity of unmodified (black), succinylated (dark green) and desuccinylated (bright green) GCDH determined by using PMS/DCPIP as artificial electron acceptors and Succinyl-CoA as electron donor (mean ± SD, n=6, 8, and 7 for unmodified, modified and deacylated GCDH respectively; * = p-value ≤ 0.05). (G) Succinyl-K sites as identified by label-free quantitative LC-MS/MS on recombinant GCDH are mapped on full-length human GCDH protein.
    Figure Legend Snippet: (A) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin from 293T SIRT5 crWT or crKO cells grown in complete media or acylation media (DMEM - glucose, - glutamine, - pyruvate, + 10% FBS). Blots are representative of at least three independent experiments and quantitative values of succinyl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 2. Same experiment as , blotted for Succ-K). (B) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or glutarylation media (EBSS +50mM HEPES, +0.8mM Lysine) with or without co-expressed SIRT5-HA. Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 1. Same experiment as , blotted for Succ-K). (C) Immunoblot for immuno-purified GCDH-FLAG by Flag-M2 resin or succinyl-proteins by anti-succinyl-lysine antibody (Succ-K) from 293T SIRT5 CRISPR cells grown in complete media media. Blots representative of at least three independent experiments. (D) Immunoblot of immuno-purified GCDH-FLAG by Flag-M2 resin from 293T SIRT5 CRISPR cells grown in complete media with or without co-expressed SIRT5-HA. Blots representative of at least three independent experiments and quantitative values of succinyl-lysine intensity normalized to FLAG intensity expressed as rations relative to control (overexpressed GCDH-FLAG, lane 2. Same experiment as , blotted for Succ-K) (E) Immunoblot of chemically modified GCDH (hGCDH-6xHIS) using succinyl-CoA with or without incubation with recombinant SIRT5 (mSIRT5-6xHIS). Quantitative values of succinyl-lysine intensity normalized to total protein are expressed as ratios relative to control (succinyl-modified recombinant GCDH, lane 2) (F) Enzymatic activity of unmodified (black), succinylated (dark green) and desuccinylated (bright green) GCDH determined by using PMS/DCPIP as artificial electron acceptors and Succinyl-CoA as electron donor (mean ± SD, n=6, 8, and 7 for unmodified, modified and deacylated GCDH respectively; * = p-value ≤ 0.05). (G) Succinyl-K sites as identified by label-free quantitative LC-MS/MS on recombinant GCDH are mapped on full-length human GCDH protein.

    Techniques Used: Western Blot, Purification, CRISPR, Modification, Incubation, Recombinant, Activity Assay, Liquid Chromatography with Mass Spectroscopy

    (A) Enzymatic activity of unmodified (black), glutarylated (dark purple) and de-glutarylated (light purple) GCDH determined by using ETF/DCPIP as an electron acceptors and Glutaryl-CoA as electron donor (mean ± SD, n = 4, 4, and 5 for unmodified, modified and deacylated GCDH respectively, *: p-value ≤ 0.05). (B) Enzymatic activity of unmodified (black), succinylated (dark green) and de-succinylated (light green) GCDH determined by using ETF/DCPIP as an electron acceptors and Succinyl-CoA as electron donor (mean ± SD, n = 4, 4, and 3 for unmodified, modified and deacylated GCDH respectively, *: p-value ≤ 0.05). (C) Immunoblot of blue-native PAGE separated GCDH tetramer and SDS-PAGE for denatured GCDH isolated from liver mitochondria of 24 h fed SIRT5WT and SIRT5KO mice. Fed GCDHKO mouse liver mitochondrial lysates used as control to identify correct GCDH tetramer complex. (D-E) Homotetrameric structure of human GCDH with each subunit colored separately (purple, blue, red, and green). Yellow sticks indicate modified lysine residues. The FAD cofactor and CoA substrate are black and light gray spheres, respectively. (F) Quantitation of GCDH tetramer intensity normalized to ETF complex intensity. Data representative of two independent experiments (mean ± SD, n = 3 for both SIRT5 WT and SIRT5 KO). (G) Far-UV CD spectra for glutarylated-GCDH (purple) and unmodified GCDH (black). (H) Thermal stability profiles for glutarylated-GCDH (open circles, purple curve) and unmodified GCDH (closed squares, dark curve). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperature were determined. (I) Far-UV CD spectra for succinylated-GCDH (green) and unmodified GCDH (black). (J) Thermal stability profiles for succinylated-GCDH (open circles, green curve) and unmodified GCDH (closed squares, green curve). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperature was determined.
    Figure Legend Snippet: (A) Enzymatic activity of unmodified (black), glutarylated (dark purple) and de-glutarylated (light purple) GCDH determined by using ETF/DCPIP as an electron acceptors and Glutaryl-CoA as electron donor (mean ± SD, n = 4, 4, and 5 for unmodified, modified and deacylated GCDH respectively, *: p-value ≤ 0.05). (B) Enzymatic activity of unmodified (black), succinylated (dark green) and de-succinylated (light green) GCDH determined by using ETF/DCPIP as an electron acceptors and Succinyl-CoA as electron donor (mean ± SD, n = 4, 4, and 3 for unmodified, modified and deacylated GCDH respectively, *: p-value ≤ 0.05). (C) Immunoblot of blue-native PAGE separated GCDH tetramer and SDS-PAGE for denatured GCDH isolated from liver mitochondria of 24 h fed SIRT5WT and SIRT5KO mice. Fed GCDHKO mouse liver mitochondrial lysates used as control to identify correct GCDH tetramer complex. (D-E) Homotetrameric structure of human GCDH with each subunit colored separately (purple, blue, red, and green). Yellow sticks indicate modified lysine residues. The FAD cofactor and CoA substrate are black and light gray spheres, respectively. (F) Quantitation of GCDH tetramer intensity normalized to ETF complex intensity. Data representative of two independent experiments (mean ± SD, n = 3 for both SIRT5 WT and SIRT5 KO). (G) Far-UV CD spectra for glutarylated-GCDH (purple) and unmodified GCDH (black). (H) Thermal stability profiles for glutarylated-GCDH (open circles, purple curve) and unmodified GCDH (closed squares, dark curve). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperature were determined. (I) Far-UV CD spectra for succinylated-GCDH (green) and unmodified GCDH (black). (J) Thermal stability profiles for succinylated-GCDH (open circles, green curve) and unmodified GCDH (closed squares, green curve). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperature was determined.

    Techniques Used: Activity Assay, Modification, Western Blot, Blue Native PAGE, SDS Page, Isolation, Quantitation Assay

    (A) Schematic of lysine oxidation enzymes with steps that release carbon dioxide (CO 2 ). (B) Oxidation of [U- 14 C]-lysine to [ 14 C]-CO 2 in 293T SIRT5 crWT and crKO cells. Data representative of three independent experiments (mean ± SD, n = 6; * = p-value ≤ 0.05). (C) Oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from 3h starved 293T SIRT5 crWT and crKO cells. Data representative of single experiment (mean ± SD, n = 4; * = p-value ≤ 0.05). (D) Oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from SIRT5WT and SIRT5KO mouse liver. Data representative of single experiment (mean ± SD, n = 6, 8 for SIRT5WT and SIRT5KO respectively; * =p-value ≤ 0.05).
    Figure Legend Snippet: (A) Schematic of lysine oxidation enzymes with steps that release carbon dioxide (CO 2 ). (B) Oxidation of [U- 14 C]-lysine to [ 14 C]-CO 2 in 293T SIRT5 crWT and crKO cells. Data representative of three independent experiments (mean ± SD, n = 6; * = p-value ≤ 0.05). (C) Oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from 3h starved 293T SIRT5 crWT and crKO cells. Data representative of single experiment (mean ± SD, n = 4; * = p-value ≤ 0.05). (D) Oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from SIRT5WT and SIRT5KO mouse liver. Data representative of single experiment (mean ± SD, n = 6, 8 for SIRT5WT and SIRT5KO respectively; * =p-value ≤ 0.05).

    Techniques Used: Isolation

    ts 26 1  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc ts 26 1
    Ts 26 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ts 26 1/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ts 26 1 - by Bioz Stars, 2023-03
    94/100 stars

    Images

    glutaryl lysine antibody  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc glutaryl lysine antibody
    Glutaryl Lysine Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glutaryl lysine antibody/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    glutaryl lysine antibody - by Bioz Stars, 2023-03
    86/100 stars

    Images

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94
    Cell Signaling Technology Inc glutaryl lysine
    Characterization of <t>the</t> <t>SIRT5</t> crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " width="250" height="auto" />
    Glutaryl Lysine, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glutaryl lysine/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    glutaryl lysine - by Bioz Stars, 2023-03
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc ptmscan pan glutaryl lysine affinity resin
    Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " width="250" height="auto" />
    Ptmscan Pan Glutaryl Lysine Affinity Resin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ptmscan pan glutaryl lysine affinity resin/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ptmscan pan glutaryl lysine affinity resin - by Bioz Stars, 2023-03
    94/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc anti glutaryl lysine
    Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " width="250" height="auto" />
    Anti Glutaryl Lysine, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti glutaryl lysine/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti glutaryl lysine - by Bioz Stars, 2023-03
    86/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc 14943mf
    Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " width="250" height="auto" />
    14943mf, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/14943mf/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    14943mf - by Bioz Stars, 2023-03
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc glucose transporter glut2
    Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " width="250" height="auto" />
    Glucose Transporter Glut2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glucose transporter glut2/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    glucose transporter glut2 - by Bioz Stars, 2023-03
    94/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc pan glutaryl lysine ptm 1151
    Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " width="250" height="auto" />
    Pan Glutaryl Lysine Ptm 1151, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pan glutaryl lysine ptm 1151/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pan glutaryl lysine ptm 1151 - by Bioz Stars, 2023-03
    86/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc ts 26 1
    Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " width="250" height="auto" />
    Ts 26 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ts 26 1/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ts 26 1 - by Bioz Stars, 2023-03
    94/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc glutaryl lysine antibody
    Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " width="250" height="auto" />
    Glutaryl Lysine Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glutaryl lysine antibody/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    glutaryl lysine antibody - by Bioz Stars, 2023-03
    86/100 stars
      Buy from Supplier

    Image Search Results


    Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " width="100%" height="100%">

    Journal: The Journal of Biological Chemistry

    Article Title: Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice

    doi: 10.1016/j.jbc.2022.101723

    Figure Lengend Snippet: Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA.

    Article Snippet: For immunoprecipitation of endogenous SIRT5 (Millipore-Sigma #HPA022002), GCDH (Millipore-Sigma # HPA048492; Thermo # PA5-60294), glutaryl-lysine- (Cell Signaling Technologies, non-commercial #14943MF; PTMScan #26101), and succinyl-lysine- (Cell Signaling Technologies, noncommercial #13599) proteins, 1 to 10 mg of precleared lysate/500 μl of lysis buffer was incubated with 2 to 10 μg of IP antibody overnight at 4 °C.

    Techniques: CRISPR, Western Blot

    Glutarylation-state of GCDH is regulated by Sirt5. A , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin or glutaryl-proteins by anti-glutaryl-lysine antibody (Glut-K) from HEK293T cells grown in complete media. Blots representative of at least three independent experiments. B , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or acylation media (DMEM without glucose, glutamine, pyruvate, 10% FBS). Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 2). C , immunoblot of immunopurified GCDH-FLAG by Flag-M2 resin from HEK293T cells grown in complete media with or without coexpressed SIRT5-HA. Blots representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG, lane 2). D , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or glutarylation media (EBSS containing 5 mM glucose, +50 mM Hepes, +0.8 mM lysine) with or without coexpressed SIRT5-HA. Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 1). E , immunoblot for pan-glutaryl lysine immunopurified proteins by endogenous GCDH and glutaryl-lysine from 3-month-old wild-type (SIRT5WT) and Sirt5 −/− (SIRT5KO) mice liver tissue that were refed or starved for 1 h following a 24 h starvation. Red arrow indicates the GCDH band within the glutaryl blot. Blots representative of at least three mice per group (n = 3 per group). F , relative quantification of the immunoblots in ( E ). Data representative of a single experiment from six SIRT5WT and six SIRT5KO mouse livers starved for 24 h from which half were refed (3 SIRT5WT and 3 SIRT5KO) normal diet for 1 h, while the remaining half (three SIRT5WT and three SIRT5KO) continued starvation for additional 1 h (mean ± SD, n = 3 per group). WT and Gcdh −/− (GCDHKO) mice (n = 1) were used as positive and negative controls, respectively, for identifying the correct GCDH band. One-way ANOVA followed by Tukey’s post hoc test was performed for multiple comparisons across groups where ∗ p -value = 0.0173, ∗∗ p -value = 0.0018, ∗∗∗ p -value = 0.0005, ∗∗∗∗ p -value < 0.0001. DMEM, Dulbecco’s modified Eagle’s medium; EBSS, Earle's Balanced Salt Solution; endo-SIRT5, endogenous SIRT5; FBS, fetal bovine serum; GCDH, glutaryl-CoA dehydrogenase.

    Journal: The Journal of Biological Chemistry

    Article Title: Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice

    doi: 10.1016/j.jbc.2022.101723

    Figure Lengend Snippet: Glutarylation-state of GCDH is regulated by Sirt5. A , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin or glutaryl-proteins by anti-glutaryl-lysine antibody (Glut-K) from HEK293T cells grown in complete media. Blots representative of at least three independent experiments. B , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or acylation media (DMEM without glucose, glutamine, pyruvate, 10% FBS). Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 2). C , immunoblot of immunopurified GCDH-FLAG by Flag-M2 resin from HEK293T cells grown in complete media with or without coexpressed SIRT5-HA. Blots representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG, lane 2). D , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or glutarylation media (EBSS containing 5 mM glucose, +50 mM Hepes, +0.8 mM lysine) with or without coexpressed SIRT5-HA. Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 1). E , immunoblot for pan-glutaryl lysine immunopurified proteins by endogenous GCDH and glutaryl-lysine from 3-month-old wild-type (SIRT5WT) and Sirt5 −/− (SIRT5KO) mice liver tissue that were refed or starved for 1 h following a 24 h starvation. Red arrow indicates the GCDH band within the glutaryl blot. Blots representative of at least three mice per group (n = 3 per group). F , relative quantification of the immunoblots in ( E ). Data representative of a single experiment from six SIRT5WT and six SIRT5KO mouse livers starved for 24 h from which half were refed (3 SIRT5WT and 3 SIRT5KO) normal diet for 1 h, while the remaining half (three SIRT5WT and three SIRT5KO) continued starvation for additional 1 h (mean ± SD, n = 3 per group). WT and Gcdh −/− (GCDHKO) mice (n = 1) were used as positive and negative controls, respectively, for identifying the correct GCDH band. One-way ANOVA followed by Tukey’s post hoc test was performed for multiple comparisons across groups where ∗ p -value = 0.0173, ∗∗ p -value = 0.0018, ∗∗∗ p -value = 0.0005, ∗∗∗∗ p -value < 0.0001. DMEM, Dulbecco’s modified Eagle’s medium; EBSS, Earle's Balanced Salt Solution; endo-SIRT5, endogenous SIRT5; FBS, fetal bovine serum; GCDH, glutaryl-CoA dehydrogenase.

    Article Snippet: For immunoprecipitation of endogenous SIRT5 (Millipore-Sigma #HPA022002), GCDH (Millipore-Sigma # HPA048492; Thermo # PA5-60294), glutaryl-lysine- (Cell Signaling Technologies, non-commercial #14943MF; PTMScan #26101), and succinyl-lysine- (Cell Signaling Technologies, noncommercial #13599) proteins, 1 to 10 mg of precleared lysate/500 μl of lysis buffer was incubated with 2 to 10 μg of IP antibody overnight at 4 °C.

    Techniques: Western Blot, Modification

    Glutarylation impairs GCDH activity and SIRT5 partially restores it. A , immunoblot of chemically modified GCDH (hGCDH-6xHIS) using glutaryl-CoA with or without incubation with recombinant SIRT5 (mSIRT5-6xHIS). Quantitative values of glutaryl-lysine intensity normalized to total protein are expressed as ratios relative to control (glutaryl-modified recombinant GCDH, lane 2). B , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and deglutarylated ( light purple ) GCDH determined by using PMS/DCPIP as artificial electron acceptors and glutaryl-CoA as electron donor (mean ± SD, n = 6, 6, and 5 for unmodified, modified, and deacylated GCDH respectively; ∗ p -value ≤ 0.05). C , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and de-glutarylated ( light purple ) GCDH determined by using ETF/DCPIP as an electron acceptor and glutaryl-CoA as electron donor (mean ± SD, n = 4, 4, and 5 for unmodified, modified, and deacylated GCDH respectively, ∗ p -value ≤ 0.05). D and E , glutaryl-lysine sites identified by label-free quantitative LC-MS/MS on recombinant GCDH mapped to full-length human GCDH protein schematic with domain and residues important for cofactor, substrate, or tetramer interactions. Panel D shows glutaryl-lysine sites in chemically glutarylated GCDH sample expressed as a ratio over unmodified GCDH (glutarylation: glutarylated GCDH/unmodified). Panel E shows glutaryl-lysine sites on chemically glutarylated GCDH altered by SIRT5 incubation expressed as a ratio over glutarylated GCDH (deglutarylation: (glutarylated GCDH + SIRT5)/glutarylated GCDH). Plots representing Log 2 fold change (y-axis) and p -value (larger circle size = more significant p -value). F and G , homotetrameric structure of human GCDH with each subunit colored separately ( purple , blue , red , and green ). Yellow sticks indicate modified lysine residues. The FAD cofactor and CoA substrate are black and light gray spheres , respectively. H , far-UV CD spectra for glutarylated GCDH ( purple ) and unmodified GCDH ( black ) corrected for protein concentration (5 μM). I , thermal stability profiles for glutarylated GCDH ( open circles , purple curve ) and unmodified GCDH ( closed squares , dark curve ). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperatures were determined. J , immunoblot of native-PAGE separated GCDH tetramer and SDS-PAGE for denatured GCDH isolated from liver mitochondria of 24 h starved SIRT5WT and SIRT5KO mice. K , quantitation of GCDH tetramer intensity normalized to ETF complex intensity. Data representative of two independent experiments (mean ± SD, n = 3 for both SIRT5WT and SIRT5KO). ETF, electron transfer flavoprotein; GCDH, glutaryl-CoA dehydrogenase; SIRT5, sirtuin 5.

    Journal: The Journal of Biological Chemistry

    Article Title: Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice

    doi: 10.1016/j.jbc.2022.101723

    Figure Lengend Snippet: Glutarylation impairs GCDH activity and SIRT5 partially restores it. A , immunoblot of chemically modified GCDH (hGCDH-6xHIS) using glutaryl-CoA with or without incubation with recombinant SIRT5 (mSIRT5-6xHIS). Quantitative values of glutaryl-lysine intensity normalized to total protein are expressed as ratios relative to control (glutaryl-modified recombinant GCDH, lane 2). B , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and deglutarylated ( light purple ) GCDH determined by using PMS/DCPIP as artificial electron acceptors and glutaryl-CoA as electron donor (mean ± SD, n = 6, 6, and 5 for unmodified, modified, and deacylated GCDH respectively; ∗ p -value ≤ 0.05). C , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and de-glutarylated ( light purple ) GCDH determined by using ETF/DCPIP as an electron acceptor and glutaryl-CoA as electron donor (mean ± SD, n = 4, 4, and 5 for unmodified, modified, and deacylated GCDH respectively, ∗ p -value ≤ 0.05). D and E , glutaryl-lysine sites identified by label-free quantitative LC-MS/MS on recombinant GCDH mapped to full-length human GCDH protein schematic with domain and residues important for cofactor, substrate, or tetramer interactions. Panel D shows glutaryl-lysine sites in chemically glutarylated GCDH sample expressed as a ratio over unmodified GCDH (glutarylation: glutarylated GCDH/unmodified). Panel E shows glutaryl-lysine sites on chemically glutarylated GCDH altered by SIRT5 incubation expressed as a ratio over glutarylated GCDH (deglutarylation: (glutarylated GCDH + SIRT5)/glutarylated GCDH). Plots representing Log 2 fold change (y-axis) and p -value (larger circle size = more significant p -value). F and G , homotetrameric structure of human GCDH with each subunit colored separately ( purple , blue , red , and green ). Yellow sticks indicate modified lysine residues. The FAD cofactor and CoA substrate are black and light gray spheres , respectively. H , far-UV CD spectra for glutarylated GCDH ( purple ) and unmodified GCDH ( black ) corrected for protein concentration (5 μM). I , thermal stability profiles for glutarylated GCDH ( open circles , purple curve ) and unmodified GCDH ( closed squares , dark curve ). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperatures were determined. J , immunoblot of native-PAGE separated GCDH tetramer and SDS-PAGE for denatured GCDH isolated from liver mitochondria of 24 h starved SIRT5WT and SIRT5KO mice. K , quantitation of GCDH tetramer intensity normalized to ETF complex intensity. Data representative of two independent experiments (mean ± SD, n = 3 for both SIRT5WT and SIRT5KO). ETF, electron transfer flavoprotein; GCDH, glutaryl-CoA dehydrogenase; SIRT5, sirtuin 5.

    Article Snippet: For immunoprecipitation of endogenous SIRT5 (Millipore-Sigma #HPA022002), GCDH (Millipore-Sigma # HPA048492; Thermo # PA5-60294), glutaryl-lysine- (Cell Signaling Technologies, non-commercial #14943MF; PTMScan #26101), and succinyl-lysine- (Cell Signaling Technologies, noncommercial #13599) proteins, 1 to 10 mg of precleared lysate/500 μl of lysis buffer was incubated with 2 to 10 μg of IP antibody overnight at 4 °C.

    Techniques: Activity Assay, Western Blot, Modification, Incubation, Recombinant, Liquid Chromatography with Mass Spectroscopy, Protein Concentration, Clear Native PAGE, SDS Page, Isolation, Quantitation Assay

    SIRT5 ablation impairs lysine oxidation and glutaryl-CoA oxidation in cells and mice. A , schematic of lysine oxidation enzymes with steps that release carbon dioxide (CO 2 ). B , oxidation of [U- 14 C]-lysine to [ 14 C]-CO 2 in 293T SIRT5 crWT and crKO cells. Data representative of three independent experiments (mean ± SD, n = 6; ∗ p -value ≤ 0.05). C , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from 3 h starved 293T SIRT5 crWT and crKO cells. Data representative of single experiment (mean ± SD, n = 4; ∗ p -value ≤ 0.05). D , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from SIRT5WT and SIRT5KO mouse liver. Data representative of single experiment (mean ± SD, n = 6, 8 for SIRT5WT and SIRT5KO respectively; ∗ p -value ≤ 0.05). SIRT5, sirtuin 5.

    Journal: The Journal of Biological Chemistry

    Article Title: Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice

    doi: 10.1016/j.jbc.2022.101723

    Figure Lengend Snippet: SIRT5 ablation impairs lysine oxidation and glutaryl-CoA oxidation in cells and mice. A , schematic of lysine oxidation enzymes with steps that release carbon dioxide (CO 2 ). B , oxidation of [U- 14 C]-lysine to [ 14 C]-CO 2 in 293T SIRT5 crWT and crKO cells. Data representative of three independent experiments (mean ± SD, n = 6; ∗ p -value ≤ 0.05). C , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from 3 h starved 293T SIRT5 crWT and crKO cells. Data representative of single experiment (mean ± SD, n = 4; ∗ p -value ≤ 0.05). D , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from SIRT5WT and SIRT5KO mouse liver. Data representative of single experiment (mean ± SD, n = 6, 8 for SIRT5WT and SIRT5KO respectively; ∗ p -value ≤ 0.05). SIRT5, sirtuin 5.

    Article Snippet: For immunoprecipitation of endogenous SIRT5 (Millipore-Sigma #HPA022002), GCDH (Millipore-Sigma # HPA048492; Thermo # PA5-60294), glutaryl-lysine- (Cell Signaling Technologies, non-commercial #14943MF; PTMScan #26101), and succinyl-lysine- (Cell Signaling Technologies, noncommercial #13599) proteins, 1 to 10 mg of precleared lysate/500 μl of lysis buffer was incubated with 2 to 10 μg of IP antibody overnight at 4 °C.

    Techniques: Isolation

    Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " width="100%" height="100%">

    Journal: The Journal of Biological Chemistry

    Article Title: Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice

    doi: 10.1016/j.jbc.2022.101723

    Figure Lengend Snippet: Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA.

    Article Snippet: We immunopurified glutarylated proteins using the PTMScan pan-glutaryl-lysine affinity resin (Cell Signaling Technologies) and immunoblotted for endogenous GCDH.

    Techniques: CRISPR, Western Blot

    Glutarylation-state of GCDH is regulated by Sirt5. A , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin or glutaryl-proteins by anti-glutaryl-lysine antibody (Glut-K) from HEK293T cells grown in complete media. Blots representative of at least three independent experiments. B , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or acylation media (DMEM without glucose, glutamine, pyruvate, 10% FBS). Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 2). C , immunoblot of immunopurified GCDH-FLAG by Flag-M2 resin from HEK293T cells grown in complete media with or without coexpressed SIRT5-HA. Blots representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG, lane 2). D , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or glutarylation media (EBSS containing 5 mM glucose, +50 mM Hepes, +0.8 mM lysine) with or without coexpressed SIRT5-HA. Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 1). E , immunoblot for pan-glutaryl lysine immunopurified proteins by endogenous GCDH and glutaryl-lysine from 3-month-old wild-type (SIRT5WT) and Sirt5 −/− (SIRT5KO) mice liver tissue that were refed or starved for 1 h following a 24 h starvation. Red arrow indicates the GCDH band within the glutaryl blot. Blots representative of at least three mice per group (n = 3 per group). F , relative quantification of the immunoblots in ( E ). Data representative of a single experiment from six SIRT5WT and six SIRT5KO mouse livers starved for 24 h from which half were refed (3 SIRT5WT and 3 SIRT5KO) normal diet for 1 h, while the remaining half (three SIRT5WT and three SIRT5KO) continued starvation for additional 1 h (mean ± SD, n = 3 per group). WT and Gcdh −/− (GCDHKO) mice (n = 1) were used as positive and negative controls, respectively, for identifying the correct GCDH band. One-way ANOVA followed by Tukey’s post hoc test was performed for multiple comparisons across groups where ∗ p -value = 0.0173, ∗∗ p -value = 0.0018, ∗∗∗ p -value = 0.0005, ∗∗∗∗ p -value < 0.0001. DMEM, Dulbecco’s modified Eagle’s medium; EBSS, Earle's Balanced Salt Solution; endo-SIRT5, endogenous SIRT5; FBS, fetal bovine serum; GCDH, glutaryl-CoA dehydrogenase.

    Journal: The Journal of Biological Chemistry

    Article Title: Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice

    doi: 10.1016/j.jbc.2022.101723

    Figure Lengend Snippet: Glutarylation-state of GCDH is regulated by Sirt5. A , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin or glutaryl-proteins by anti-glutaryl-lysine antibody (Glut-K) from HEK293T cells grown in complete media. Blots representative of at least three independent experiments. B , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or acylation media (DMEM without glucose, glutamine, pyruvate, 10% FBS). Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 2). C , immunoblot of immunopurified GCDH-FLAG by Flag-M2 resin from HEK293T cells grown in complete media with or without coexpressed SIRT5-HA. Blots representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG, lane 2). D , immunoblot for immunopurified GCDH-FLAG by Flag-M2 resin from SIRT5 crWT or crKO cells grown in complete media or glutarylation media (EBSS containing 5 mM glucose, +50 mM Hepes, +0.8 mM lysine) with or without coexpressed SIRT5-HA. Blots are representative of at least three independent experiments and quantitative values of glutaryl-lysine intensity normalized to FLAG intensity expressed as ratios relative to control (overexpressed GCDH-FLAG in SIRT5 crWT cells grown in complete media, lane 1). E , immunoblot for pan-glutaryl lysine immunopurified proteins by endogenous GCDH and glutaryl-lysine from 3-month-old wild-type (SIRT5WT) and Sirt5 −/− (SIRT5KO) mice liver tissue that were refed or starved for 1 h following a 24 h starvation. Red arrow indicates the GCDH band within the glutaryl blot. Blots representative of at least three mice per group (n = 3 per group). F , relative quantification of the immunoblots in ( E ). Data representative of a single experiment from six SIRT5WT and six SIRT5KO mouse livers starved for 24 h from which half were refed (3 SIRT5WT and 3 SIRT5KO) normal diet for 1 h, while the remaining half (three SIRT5WT and three SIRT5KO) continued starvation for additional 1 h (mean ± SD, n = 3 per group). WT and Gcdh −/− (GCDHKO) mice (n = 1) were used as positive and negative controls, respectively, for identifying the correct GCDH band. One-way ANOVA followed by Tukey’s post hoc test was performed for multiple comparisons across groups where ∗ p -value = 0.0173, ∗∗ p -value = 0.0018, ∗∗∗ p -value = 0.0005, ∗∗∗∗ p -value < 0.0001. DMEM, Dulbecco’s modified Eagle’s medium; EBSS, Earle's Balanced Salt Solution; endo-SIRT5, endogenous SIRT5; FBS, fetal bovine serum; GCDH, glutaryl-CoA dehydrogenase.

    Article Snippet: We immunopurified glutarylated proteins using the PTMScan pan-glutaryl-lysine affinity resin (Cell Signaling Technologies) and immunoblotted for endogenous GCDH.

    Techniques: Western Blot, Modification

    Glutarylation impairs GCDH activity and SIRT5 partially restores it. A , immunoblot of chemically modified GCDH (hGCDH-6xHIS) using glutaryl-CoA with or without incubation with recombinant SIRT5 (mSIRT5-6xHIS). Quantitative values of glutaryl-lysine intensity normalized to total protein are expressed as ratios relative to control (glutaryl-modified recombinant GCDH, lane 2). B , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and deglutarylated ( light purple ) GCDH determined by using PMS/DCPIP as artificial electron acceptors and glutaryl-CoA as electron donor (mean ± SD, n = 6, 6, and 5 for unmodified, modified, and deacylated GCDH respectively; ∗ p -value ≤ 0.05). C , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and de-glutarylated ( light purple ) GCDH determined by using ETF/DCPIP as an electron acceptor and glutaryl-CoA as electron donor (mean ± SD, n = 4, 4, and 5 for unmodified, modified, and deacylated GCDH respectively, ∗ p -value ≤ 0.05). D and E , glutaryl-lysine sites identified by label-free quantitative LC-MS/MS on recombinant GCDH mapped to full-length human GCDH protein schematic with domain and residues important for cofactor, substrate, or tetramer interactions. Panel D shows glutaryl-lysine sites in chemically glutarylated GCDH sample expressed as a ratio over unmodified GCDH (glutarylation: glutarylated GCDH/unmodified). Panel E shows glutaryl-lysine sites on chemically glutarylated GCDH altered by SIRT5 incubation expressed as a ratio over glutarylated GCDH (deglutarylation: (glutarylated GCDH + SIRT5)/glutarylated GCDH). Plots representing Log 2 fold change (y-axis) and p -value (larger circle size = more significant p -value). F and G , homotetrameric structure of human GCDH with each subunit colored separately ( purple , blue , red , and green ). Yellow sticks indicate modified lysine residues. The FAD cofactor and CoA substrate are black and light gray spheres , respectively. H , far-UV CD spectra for glutarylated GCDH ( purple ) and unmodified GCDH ( black ) corrected for protein concentration (5 μM). I , thermal stability profiles for glutarylated GCDH ( open circles , purple curve ) and unmodified GCDH ( closed squares , dark curve ). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperatures were determined. J , immunoblot of native-PAGE separated GCDH tetramer and SDS-PAGE for denatured GCDH isolated from liver mitochondria of 24 h starved SIRT5WT and SIRT5KO mice. K , quantitation of GCDH tetramer intensity normalized to ETF complex intensity. Data representative of two independent experiments (mean ± SD, n = 3 for both SIRT5WT and SIRT5KO). ETF, electron transfer flavoprotein; GCDH, glutaryl-CoA dehydrogenase; SIRT5, sirtuin 5.

    Journal: The Journal of Biological Chemistry

    Article Title: Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice

    doi: 10.1016/j.jbc.2022.101723

    Figure Lengend Snippet: Glutarylation impairs GCDH activity and SIRT5 partially restores it. A , immunoblot of chemically modified GCDH (hGCDH-6xHIS) using glutaryl-CoA with or without incubation with recombinant SIRT5 (mSIRT5-6xHIS). Quantitative values of glutaryl-lysine intensity normalized to total protein are expressed as ratios relative to control (glutaryl-modified recombinant GCDH, lane 2). B , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and deglutarylated ( light purple ) GCDH determined by using PMS/DCPIP as artificial electron acceptors and glutaryl-CoA as electron donor (mean ± SD, n = 6, 6, and 5 for unmodified, modified, and deacylated GCDH respectively; ∗ p -value ≤ 0.05). C , enzymatic activity of unmodified ( black ), glutarylated ( dark purple ), and de-glutarylated ( light purple ) GCDH determined by using ETF/DCPIP as an electron acceptor and glutaryl-CoA as electron donor (mean ± SD, n = 4, 4, and 5 for unmodified, modified, and deacylated GCDH respectively, ∗ p -value ≤ 0.05). D and E , glutaryl-lysine sites identified by label-free quantitative LC-MS/MS on recombinant GCDH mapped to full-length human GCDH protein schematic with domain and residues important for cofactor, substrate, or tetramer interactions. Panel D shows glutaryl-lysine sites in chemically glutarylated GCDH sample expressed as a ratio over unmodified GCDH (glutarylation: glutarylated GCDH/unmodified). Panel E shows glutaryl-lysine sites on chemically glutarylated GCDH altered by SIRT5 incubation expressed as a ratio over glutarylated GCDH (deglutarylation: (glutarylated GCDH + SIRT5)/glutarylated GCDH). Plots representing Log 2 fold change (y-axis) and p -value (larger circle size = more significant p -value). F and G , homotetrameric structure of human GCDH with each subunit colored separately ( purple , blue , red , and green ). Yellow sticks indicate modified lysine residues. The FAD cofactor and CoA substrate are black and light gray spheres , respectively. H , far-UV CD spectra for glutarylated GCDH ( purple ) and unmodified GCDH ( black ) corrected for protein concentration (5 μM). I , thermal stability profiles for glutarylated GCDH ( open circles , purple curve ) and unmodified GCDH ( closed squares , dark curve ). The solid lines represent two-state sigmoid curves from which the apparent midpoint temperatures were determined. J , immunoblot of native-PAGE separated GCDH tetramer and SDS-PAGE for denatured GCDH isolated from liver mitochondria of 24 h starved SIRT5WT and SIRT5KO mice. K , quantitation of GCDH tetramer intensity normalized to ETF complex intensity. Data representative of two independent experiments (mean ± SD, n = 3 for both SIRT5WT and SIRT5KO). ETF, electron transfer flavoprotein; GCDH, glutaryl-CoA dehydrogenase; SIRT5, sirtuin 5.

    Article Snippet: We immunopurified glutarylated proteins using the PTMScan pan-glutaryl-lysine affinity resin (Cell Signaling Technologies) and immunoblotted for endogenous GCDH.

    Techniques: Activity Assay, Western Blot, Modification, Incubation, Recombinant, Liquid Chromatography with Mass Spectroscopy, Protein Concentration, Clear Native PAGE, SDS Page, Isolation, Quantitation Assay

    SIRT5 ablation impairs lysine oxidation and glutaryl-CoA oxidation in cells and mice. A , schematic of lysine oxidation enzymes with steps that release carbon dioxide (CO 2 ). B , oxidation of [U- 14 C]-lysine to [ 14 C]-CO 2 in 293T SIRT5 crWT and crKO cells. Data representative of three independent experiments (mean ± SD, n = 6; ∗ p -value ≤ 0.05). C , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from 3 h starved 293T SIRT5 crWT and crKO cells. Data representative of single experiment (mean ± SD, n = 4; ∗ p -value ≤ 0.05). D , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from SIRT5WT and SIRT5KO mouse liver. Data representative of single experiment (mean ± SD, n = 6, 8 for SIRT5WT and SIRT5KO respectively; ∗ p -value ≤ 0.05). SIRT5, sirtuin 5.

    Journal: The Journal of Biological Chemistry

    Article Title: Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice

    doi: 10.1016/j.jbc.2022.101723

    Figure Lengend Snippet: SIRT5 ablation impairs lysine oxidation and glutaryl-CoA oxidation in cells and mice. A , schematic of lysine oxidation enzymes with steps that release carbon dioxide (CO 2 ). B , oxidation of [U- 14 C]-lysine to [ 14 C]-CO 2 in 293T SIRT5 crWT and crKO cells. Data representative of three independent experiments (mean ± SD, n = 6; ∗ p -value ≤ 0.05). C , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from 3 h starved 293T SIRT5 crWT and crKO cells. Data representative of single experiment (mean ± SD, n = 4; ∗ p -value ≤ 0.05). D , oxidation of [1, 5- 14 C]-glutaryl-CoA to [ 14 C]-CO 2 in mitochondria isolated from SIRT5WT and SIRT5KO mouse liver. Data representative of single experiment (mean ± SD, n = 6, 8 for SIRT5WT and SIRT5KO respectively; ∗ p -value ≤ 0.05). SIRT5, sirtuin 5.

    Article Snippet: We immunopurified glutarylated proteins using the PTMScan pan-glutaryl-lysine affinity resin (Cell Signaling Technologies) and immunoblotted for endogenous GCDH.

    Techniques: Isolation

    Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, <xref ref-type=Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA. " width="100%" height="100%">

    Journal: The Journal of Biological Chemistry

    Article Title: Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice

    doi: 10.1016/j.jbc.2022.101723

    Figure Lengend Snippet: Characterization of the SIRT5 crKO cell line. A , schematic of the CRISPR-Cas9 system used to generate the SIRT5 crKO cell line. B , schematic of the human SIRT5 gene showing the sites of crRNA targets within Exon5/4 the four known SIRT5 coding transcripts in humans. C , immunoblot for SIRT5 protein from HEK293T crWT ( circles ) clone and crKO ( blank ) clone (using CRISPR guide E, Table S1 ). D – F , immunoblots of SIRT5 crWT and crKO whole-cell lysates blotted using antibodies against glutaryl-lysine ( D ), glutaryl-succinyl-lysine ( E ), and malonyl-lysine ( F ). G – I , relative quantification of acylated proteins normalized to β-actin levels: glutarylation ( G ), succinylation ( H ), and malonylation ( I ) (mean ± SD, n = 3, ∗ p -value ≤ 0.05). crRNA, crispr RNA; PAM, protospacer adjacent motif; SIRT5, sirtuin 5; tracrRNA, trans-activating crispr RNA.

    Article Snippet: Antibodies: anti-MG-lysine (Millipore-Sigma # ABS2120-25UG), anti-SIRT5 (Millipore-Sigma #HPA022002 [for human SIRT5] and Cell Signaling Technologies #8782 [for mouse SIRT5]), anti-GCDH (Millipore-Sigma # HPA048492), mouse anti-β-actin (Cell Signaling Technologies, #3700), rabbit anti-β-actin (Cell Signaling Technologies #8457), anti-glutaryl-lysine (Cell Signaling Technologies, noncommercial #14943MF and PTM-Biolabs #1151), anti-succinyl-lysine (Cell Signaling Technologies, noncommercial # 13599 and PTM-Biolabs #401), anti-malonyl-lysine (Cell Signaling Technologies #14942), anti-acetyl-lysine (Cell Signaling Technologies, #9441), IRDye 680RD donkey anti-mouse IgG (LI-COR #926-68072), and IRDye 800CW donkey anti-rabbit IgG (LI-COR #926-32213).

    Techniques: CRISPR, Western Blot